The balance between donor T cell anergy and suppression versus lethal graft-versus-host disease is determined by host conditioning
- PMID: 12421935
- DOI: 10.4049/jimmunol.169.10.5581
The balance between donor T cell anergy and suppression versus lethal graft-versus-host disease is determined by host conditioning
Abstract
Graft-vs-host disease (GVHD) remains the most life-threatening complication following the transfer of allogeneic bone marrow into immunocompromised hosts. Transferred alloreactive T cells respond in a complex manner. While massive T cell expansion is observed upon entry into an allogeneic environment, anergy, apoptosis, and repertoire selection are also observed. The study presented here shows that alloreactive T cell expansion and differentiation vs anergy and suppression are dramatically influenced by host conditioning. Using alloreactive CD4(+) and CD8(+) TCR transgenic (Tg) T cells, a novel GVHD model is presented that allows for the visualization of how alloreactive T cells behave when host conditioning is manipulated. Following the transfer of alloreactive CD4(+) and CD8(+) TCR Tg T cells into sublethally irradiated hosts, both Tg T cells populations expand, develop effector function, and cause GVHD. In contrast, when Tg T cells are transferred in non-irradiated hosts, expansion is observed, but there is no development of effector function or disease. Assessment of CD4(+) Tg T cell function following transfer into non-irradiated hosts reveals that these CD4(+) Tg cells are profoundly anergic and have acquired a regulatory function, as manifested in their ability to suppress the expansion of naive TCR Tg T cells in vitro and in vivo as well as the development of GVHD. These findings underscore the decisive effect of the inflammatory environment created by irradiation in determining the ultimate fate and function of alloreactive T cells in vivo
Similar articles
-
Host conditioning is a primary determinant in modulating the effect of IL-7 on murine graft-versus-host disease.J Immunol. 2004 Mar 1;172(5):3328-36. doi: 10.4049/jimmunol.172.5.3328. J Immunol. 2004. PMID: 14978141
-
CD4 T cell-mediated alloresistance to fully MHC-mismatched allogeneic bone marrow engraftment is dependent on CD40-CD40 ligand interactions, and lasting T cell tolerance is induced by bone marrow transplantation with initial blockade of this pathway.J Immunol. 2001 Mar 1;166(5):2970-81. doi: 10.4049/jimmunol.166.5.2970. J Immunol. 2001. PMID: 11207246
-
Cutting edge: sustained expansion of CD8+ T cells requires CD154 expression by Th cells in acute graft versus host disease.J Immunol. 1999 Apr 15;162(8):4373-6. J Immunol. 1999. PMID: 10201970
-
Induction of immunologic tolerance for allogeneic hematopoietic cell transplantation.Leuk Lymphoma. 2002 Jun;43(6):1159-67. doi: 10.1080/10428190290026213. Leuk Lymphoma. 2002. PMID: 12152983 Review.
-
T cells, murine chronic graft-versus-host disease and autoimmunity.J Autoimmun. 2012 Sep;39(3):240-7. doi: 10.1016/j.jaut.2012.05.017. Epub 2012 Jun 16. J Autoimmun. 2012. PMID: 22704961 Free PMC article. Review.
Cited by
-
Regulatory T-cell recovery in recipients of haploidentical nonmyeloablative hematopoietic cell transplantation with a humanized anti-CD2 mAb, MEDI-507, with or without fludarabine.Exp Hematol. 2007 Jul;35(7):1140-52. doi: 10.1016/j.exphem.2007.03.018. Exp Hematol. 2007. PMID: 17588483 Free PMC article.
-
Allospecific CD4(+) effector memory T cells do not induce graft-versus-host disease in mice.Biol Blood Marrow Transplant. 2012 Oct;18(10):1488-99. doi: 10.1016/j.bbmt.2012.07.009. Epub 2012 Jul 15. Biol Blood Marrow Transplant. 2012. PMID: 22809867 Free PMC article.
-
CD62L- memory T cells enhance T-cell regeneration after allogeneic stem cell transplantation by eliminating host resistance in mice.Blood. 2012 Jun 28;119(26):6344-53. doi: 10.1182/blood-2011-03-342055. Epub 2012 May 17. Blood. 2012. PMID: 22596261 Free PMC article.
-
Tumor-reactive CD4(+) T cells develop cytotoxic activity and eradicate large established melanoma after transfer into lymphopenic hosts.J Exp Med. 2010 Mar 15;207(3):637-50. doi: 10.1084/jem.20091918. Epub 2010 Feb 15. J Exp Med. 2010. PMID: 20156971 Free PMC article.
-
VISTA is a checkpoint regulator for naïve T cell quiescence and peripheral tolerance.Science. 2020 Jan 17;367(6475):eaay0524. doi: 10.1126/science.aay0524. Science. 2020. PMID: 31949051 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous